Hepion Pharmaceuticals Shares Rise 96% Premarket; Co Announced Wednesday Publication of Data Highlighting CRV431's Potential as a Treatment for Chronic Liver Diseases
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.